1044210-58-3 Usage
Uses
Used in Pharmaceutical Industry:
5-Cyclopropylpyridin-3-ylboronic acid is used as a building block for the synthesis of various pharmaceuticals. Its unique structural features and reactivity in coupling reactions facilitate the development of complex organic molecules with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Cyclopropylpyridin-3-ylboronic acid serves as a key intermediate in the preparation of agrochemicals. Its ability to form stable and functional organic compounds makes it instrumental in the design of new pesticides and other agricultural chemicals that can enhance crop protection and yield.
Used in Organic Synthesis:
5-Cyclopropylpyridin-3-ylboronic acid is utilized as a versatile reagent in organic synthesis. Its capacity to undergo a variety of coupling reactions allows chemists to construct complex organic molecules with specific properties, which can be tailored for various applications in research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1044210-58-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,4,2,1 and 0 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1044210-58:
(9*1)+(8*0)+(7*4)+(6*4)+(5*2)+(4*1)+(3*0)+(2*5)+(1*8)=93
93 % 10 = 3
So 1044210-58-3 is a valid CAS Registry Number.
1044210-58-3Relevant academic research and scientific papers
Theramutein modulators
-
Page/Page column 205, (2010/02/17)
This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of particular interest are inhibitors and activators of endogenous protein variants, encoded by genes which have mutated, which variants often arise or are at least first identified as having arisen following exposure to a chemical agent which is known to be an inhibitor or activator of the corresponding unmutated endogenous protein.
THERAMUTEIN MODULATORS
-
Page/Page column 242-243, (2008/12/07)
This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of particular interest are inhibitors and activators of endogenous protein variants, encoded by genes which have mutated, which variants often arise or are at least first identified as having arisen following exposure to a chemical agent which is known to be an inhibitor or activator of the corresponding unmutated endogenous protein.
